Division of Nephrology and Hypertension Archives
Treating kidney injury before it happens
May. 23, 2023—Pretreatment of an animal model with a novel compound called PHAD reduced kidney injury, suggesting it may be a good candidate for preventing kidney injury in surgical patients.
Sex-specific regulation of kidney signals
Mar. 2, 2023—Links between estrogen signaling and sodium excretion by the kidney could help explain a reduced risk of hypertension in females versus males.
Low potassium injures kidney
Jan. 19, 2023—Vanderbilt researchers have discovered that low dietary potassium causes direct kidney injury, suggesting potential new targets for treating chronic kidney disease.
VUMC researchers upend dogma about vasopressin production
Jan. 5, 2023—Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.
VUMC adopts updated kidney function equation to better guide patient care decisions
Nov. 17, 2022—In December Vanderbilt University Medical Center will again update the equation used for estimating kidney function with the goals of improving health equity and better guiding patient care decisions.
Study supports removing race from estimate of kidney function
Nov. 17, 2022—An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.
Kidney diseases research collaboration renewed
Oct. 6, 2022—Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.
Vanderbilt’s Terker wins NIH Director’s Early Independence Award
Oct. 4, 2022—Andrew Terker, MD, PhD, a physician scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.
Inflammatory driver of obesity
Aug. 25, 2022—Blocking the EGF receptor signaling pathway in immune system macrophages represents a new target for improving insulin resistance in people with obesity.
Study sheds light on the dark side of obesity
May. 12, 2022—Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity.
Schaefer named Adult Solid Organ Transplant Center medical director
Apr. 6, 2022—Heidi Schaefer, MD, has been named medical director of the Adult Solid Organ Transplant Center at Vanderbilt University Medical Center.
Gene variants increase risk of kidney failure in veterans of African ancestry with COVID-19: study
Feb. 10, 2022—Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19.
